Почетна › Рак (све врсте) › Masachuset › Boston
Kliničke studije za Рак (све врсте) u gradu Boston, MA
90 studija za Рак (све врсте) traži učesnike na lokacijama u gradu Boston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
Тражи се учесникФаза 2
- Mass General Brigham Cancer Institute, Boston
Multicenter Study for External Validation of the TB-NET Score
Тражи се учесникОпсервациона студија
- Dana-Farber Cancer Institute, Boston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Тражи се учесникФаза 1
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
A Study of YL242 in Subjects With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- US-204, Boston
Childhood Cancer Predisposition Study (CCPS)
Тражи се учесникОпсервациона студија
- Dana Farber Cancer Institute, Boston
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Тражи се учесникФаза 2
- Dana Farber Cancer Institute, Boston
Improving Care Delivery for Patients With Mental Illness and Cancer Across a Cancer Center Network
Тражи се учесник
- Massachusetts General Hospital, Boston
Pan Tumor Rollover Study
Тражи се учесникФаза 2
- Dana_Farber Cancer Institute (DFCI), Boston
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
Тражи се учесникФаза 1Здраве особе су добродошле
- Boston Medical Center, Boston
- Massachusetts General Hospital (MGH), Charlestown · 1 ми удаљено
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Massachusetts General Hospital (MG), Boston
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Тражи се учесникФаза 3
- Beth Israel Deaconess Medical Center, Boston
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Тражи се учесникФаза 3
- Dana Farber/Harvard Cancer Center, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
Тражи се учесник
- Dana-Farber Cancer Institute, Boston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- Boston Medical Center, Boston
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Тражи се учесникФаза 1
- Massachusetts General Hospital, Boston
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Тражи се учесникФаза 2/3
- Massachusetts General Hospital / Dana-Farber Cancer Institute, Boston
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- Massachusetts General Hospital, Boston
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Тражи се учесникФаза 1/2
- Dana Farber Cancer Center ( Site 4013), Boston
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Тражи се учесникФаза 1/2
- Dana-Farber Cancer Institute /ID# 271846, Boston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Тражи се учесникФаза 1
- Research Site, Boston
- Research Site, Boston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Тражи се учесник
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Тражи се учесникФаза 2
- Dana-Farber Cancer Institute, Boston
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Тражи се учесникФаза 3
- Beth Israel Deaconess Medical Center ( Site 0107), Boston
- Dana-Farber Cancer Institute ( Site 0105), Boston
Pembrolizumab, Ibrutinib and Rituximab in PCNSL
Тражи се учесникФаза 1/2
- Dana Farber Cancer Institute, Boston
- Beth Israel Deaconess Medical Center, Boston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Тражи се учесникФаза 1/2
- Dana Farber Cancer Institute, Boston
A Study of ASP3082 in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
Тражи се учесникФаза 1
- Brigham and Women's Hospital, Boston
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Тражи се учесникФаза 1/2
- Research Site, Boston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Тражи се учесникФаза 1/2
- Dana-Farber Cancer Institute, Boston
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Тражи се учесникФаза 2
- Massachusetts General Hospital /ID# 273608, Boston
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Тражи се учесникФаза 2
- Massachusetts Eye and Ear, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Тражи се учесникФаза 1/2
- Dana Farber Cancer Institute, Boston
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Тражи се учесникФаза 1/2
- Dana-Farber Cancer Institute ( Site 3013), Boston
PediRISE Feasibility
Тражи се учесник
- Boston Children's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Тражи се учесникФаза 1
- Beth Israel Deaconess Medical Center - Research, Boston
A Study of PHN-012 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- PHN-012-001 Site, Boston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Тражи се учесникОпсервациона студија
- Mass General Brigham, Boston
- Brigham and Women's Hospital, Boston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Тражи се учесникФаза 3
- Investigative Site, Boston
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Тражи се учесник
- Massachusetts General Hospital, Boston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Тражи се учесникФаза 3
- Dana-Farber Cancer Institute /ID# 279690, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- Dana Farber Cancer Institute, Boston
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
Тражи се учесник
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs
Тражи се учесник
- Dana-Farber Cancer Institute, Boston
Statins to Prevent Cancer Associated Blood Clots
Тражи се учесникФаза 4
- Beth Isreal Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Тражи се учесникФаза 2
- Dana-Farber Cancer Institute, Boston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Тражи се учесникФаза 1
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Тражи се учесникОпсервациона студија
- Dana Farber Cancer Institute, Boston
Prostate Active Surveillance Study
Тражи се учесникОпсервациона студија
- Beth Israel Deaconess Medical Center/Harvard Medical School, Boston
Lurbinectedin in FET-Fused Tumors
Тражи се учесникФаза 1/2
- Dana-Farber Cancer Institute, Boston
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Тражи се учесникФаза 1
- Massachusetts General Hospital, Boston
BRIDGE-SIC Efficacy Trial
Тражи се учесник
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Project: Every Child for Younger Patients With Cancer
Тражи се учесникОпсервациона студија
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Тражи се учесникФаза 3
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Boston Medical Center, Boston
- и још 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Тражи се учесникФаза 1/2
- Massachusetts General Hospital, Boston
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- Beth Israel Deaconess Medical Center, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Massachusetts General Hospital Cancer Center, Boston
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Тражи се учесникФаза 1
- Dana-Farber Cancer Institute, Boston
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Тражи се учесникФаза 2
- Dana-Farber Cancer Institute, Boston
Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
Тражи се учесникФаза 1
- Brigham and Women's Hospital, Boston
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
The STOP-MED CTRCD Trial
Тражи се учесникФаза 4
- Brigham and Women's Hospital, Boston
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Тражи се учесникФаза 1
- GSK Investigational Site, Boston
- GSK Investigational Site, Boston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Тражи се учесник
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Childhood Cancer Survivor Study
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Dana-Farber Cancer Institute, Boston
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Тражи се учесникФаза 1
- Beth Israel Deaconess Medical Center /ID# 252009, Boston
- Dana-Farber Cancer Institute /ID# 249642, Boston
Multisite Implementation of COMPRENDO
Тражи се учесникЗдраве особе су добродошле
- Dana Farber Cancer Institute/Boston Children's Hospital, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Тражи се учесникФаза 1/2
- Massachusetts General Hospital,, Boston
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Тражи се учесникФаза 1
- GSK Investigational Site, Boston
Video Inspired Discussions About Ethical Outcomes in Pediatrics
Тражи се учесник
- Dana Farber Cancer Institute, Boston
On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety
Тражи се учесникНаводи исплату за учеснике
- Dana Farber Cancer Institute, Boston
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Тражи се учесникФаза 1/2
- Massachusetts General Hospital, Boston
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
Тражи се учесникФаза 2
- Dana Farber Cancer Institute, Boston
Intraoperative Tumor Margin Identification With ICG Dye Imaging
Тражи се учесникФаза 2
- Massachusetts General Hospital, Boston
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
Тражи се учесник
- Dana-Farber Cancer Institute, Boston
Positron Emission Tomography (PET) Imaging of Thrombosis
Тражи се учесникФаза 1Здраве особе су добродошле
- Massachusetts General Hospital, Boston
Primary Tumor Research and Outcomes Network
Тражи се учесникОпсервациона студија
- Massachusetts General Hospital, Boston
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Тражи се учесникФаза 2
- Dana-Farber Cancer Institute /ID# 230061, Boston
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
Тражи се учесникЗдраве особе су добродошле
- Codman Square Health Center, Boston
- East Boston Neighborhood Health Center, East Boston · 2 ми удаљено
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Тражи се учесникОпсервациона студија
- Boston Children's Hospital, Boston
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Тражи се учесник
- Massachusetts General Hospital Cancer Center, Boston
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Тражи се учесникОпсервациона студија
- Massachusetts General Hospital, Boston
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
Тражи се учесник
- Harvard School of Medicine/Massachusetts General Hospital (MGH), Boston
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
Тражи се учесникФаза 1/2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs
Тражи се учесникЗдраве особе су добродошле
- Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Тражи се учесникФаза 1/2
- Massachusetts General Hospital, Boston
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Тражи се учесникФаза 1/2
- Massachusetts General Hospital, Boston
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Тражи се учесникФаза 3
- Massachusetts General Hospital, Boston
Studije za Рак (све врсте) u drugim gradovima
- Houston, TX124 студија
- New York City, NY105 студија
- Los Angeles, CA73 студија
- Nashville, TN65 студија
- Durham, NC61 студија
- Washington, DC60 студија
- Philadelphia, PA57 студија
- Arlington, VA52 студија
- Chicago, IL51 студија
- St. Louis, MO51 студија
- Atlanta, GA49 студија
- Seattle, WA48 студија
Ostale studije u gradu Boston
- Рак дојке110 студија
- Немалоклетни карцином плућа87 студија
- Рак плућа63 студија
- Колоректални карцином62 студија
- Рак јајника62 студија
- Метастатски карцином61 студија
- Рак простате56 студија
- Карцином ендометријума51 студија
- Депресија50 студија
- Затајење срца46 студија
- Многи мијелом45 студија
- Akutna mijeloidna leukemija44 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.